Search Results For :: growth for the global healthcare furniture
-
Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030
The medical membranes market is expected to grow from USD 4.31 billion in 2025 to USD 6.66 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period. The Key Players Asahi Kasei Corporation (Japan), Mann+Hummel (Germany), Sartorius AG (Germany), Merck KGaA (Germany), Solventum (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Kovalus Separation Solutions (US), and Cobetter (China).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biochips Market by Products & Services (Instruments, Software), Type (DNA Chips, Protein Chips, Lab-on-a-Chip), Application (High-throughput Screening, IVD, POC), Fabrication Technology (Microarrays, Microfluidics), & Region - Global Forecast to 2030
The global biochips market, valued at US$12,907.5 million in 2024, stood at US$14,011.6 million in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2024 to 2030, culminating in a forecasted valuation of US$21,356.4 million by the end of the period.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Life Science Instrumentation Market by Technology (Spectroscopy, Chromatography, Immunoassay, NGS, PCR, Microscopy), Application (Diagnostic, Clinical), End User (Pharma, Agriculture & Food Industry, Hospital, Diagnostic Lab) - Global Forecasts to 2031
The global Life Science Instrumentation market, valued at US$59.9 billion in 2024, stood at US$63.4 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2024 to 2030, culminating in a forecasted valuation of US$92.5 billion by the end of the period. The main drivers of the life science instrumentation market include increasing demand for advanced analytical technologies in drug discovery, genomics, and proteomics research, along with rising investments in pharmaceutical and biotechnology R&D.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Biomarkers Market by Offering (Consumables, Software, Services), Type (Safety, Efficacy), Research Area (Genomics, Proteomics), Technology (PCR, MS), Disease (Cancer, Infectious, Neurological), Application (Diagnostic, Research) - Global Forecast to 2030
The global biomarkers market, valued at US$58.07 billion in 2024, stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$104.15 billion by the end of the period. This growth is supported by the growing use of biomarkers in drug development and the increasing role of companion diagnostics in advancing precision medicine.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
MRI Systems Market by Architecture (Open, Closed), Field Strength (High Field MRI Systems & Low Field MRI Systems), Design (Portable MRI Systems, Fixed/Stationary MRI Systems), End User (Hospitals, Diagnostic Clinic), Region - Global Forecast to 2030
Global MRI systems market valued at $6.15B in 2024, reached $6.56B in 2025, and is projected to grow at a robust 6.5% CAGR, hitting $9.01B by 2030. The market for MRI systems is expected to grow significantly due to the rising burden of diseases, particularly neurological and musculoskeletal conditions, which are projected to increase in the coming years. The growing aging population, along with the increasing prevalence of chronic diseases like cancer, is likely to raise the demand for MRI systems worldwide.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Refinery Catalysts Market by Type (FCC Catalysts, Hydrotreating Catalysts, Hydrocracking Catalysts, Catalytic Reforming Catalysts), Ingredients (Zeolites, Metals, Chemical Compounds), and Region - Global Forecast to 2029
The refinery catalysts market is expected to grow from USD 5.6 billion in 2024 to USD 6.8 billion by 2029, at a CAGR of 4.0% during the forecast period. Mergers, new product launches and expansions are the major growth strategies adopted by the key players in the market. The key global players in the refinery catalysts market Albemarle Corporation (US), W R Grace (US), BASF (Germany), Haldor Topsoe (Denmark), Honeywell UOP (US), Clariant (Switzerland), Axens (France), Johnson Matthey (UK), China Petroleum and Chemical Corporation (Sinopec) (China), and Shell Catalyst & Technologies (Netherlands).
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Thin-Film Photovoltaic Market by Material (Cadmium Telluride, Copper Indium Gallium Selenide, Amorphous Silicon, Perovskite, and Organic PV), Type (Rigid, and Flexible), Component (Module, Inverter, and BOS), End Use & Region - Global Forecast to 2029
The thin-film photovoltaic market is expected to grow from USD 6.2 billion in 2024 to USD 12.4 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% during the forecast period.The key players KANEKA CORPORATION (Japan), First Solar (US), Ascent Solar Technologies, Inc. (US), Hanwha Qcells (South Korea), Oxford Photovoltaics Ltd. (UK), and SHARP CORPORATION (Japan). JA SOLAR Technology Co., Ltd. (China), AVANCIS GmbH (Germany), MiaSole (US), Solbian (Italy), SOLARA (Germany), Custom Solar BIPV Panels – MetSolar (Lithuania), Enecom S.r.l. (Italy), TRONY (China), NanoPV Solar Inc. (New Jersey), QS SOLAR (China), Heliatek (Germany), Wuxi Suntech Power Co., Ltd. (China), Jinko Solar (China), Trinasolar (China), Panasonic Holdings Corporation (Japan), Sol Voltaics (Sweden), Tandem PV, Inc. (US), SOLAR FRONTIER K.K. (Japan), and REC Solar Holdings AS (Norway) .
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
A2P Messaging Market by Application (Authentication Services, Promotional & Marketing Services, Customer Relationship Management Services, Pushed Content Services, Interactive Messaging Services, Notification & Alerts) - Global Forecast to 2029
The A2P messaging market size is projected to reach USD 84.8 billion by 2029, at a CAGR of 3.0% during the forecast period. The A2P messaging market comprises major providers, such as AT&T (US), China Mobile (China), Sinch (Sweden), Twilio (US), Infobip (UK), Vonage (US), Orange (France), Comviva (India), Route Mobile (India), BICS (Belgium), Monty Mobile (UK), Tata Communications (India), Syniverse (US), Tyntec (UK), Soprano Design (Australia), Genesys (US), Clickatell (US), CEQUENS (Egypt), MSG91 (India), Plivo (US), Mitto (Switzerland), Bird (Netherlands), Telewhale (Cyprus), EnableX.io (Singapore), TextUs (US), Voxvalley (Singapore). To increase their market share in the A2P messaging industry, these competitors have used a variety of growth methods, including partnerships, agreements, collaborations, new product releases, product enhancements, and acquisitions.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 47
